Multidrug Treatments Investigated in Smoldering Multiple Myeloma
Irene Ghobrial, MD discusses multiple trials and their significance for treating patients with smoldering multiple myeloma and newly diagnosed multiple myeloma.
Dr. Ghobrial Discusses the Importance of the Multiple Myeloma Research Foundation's CureCloud Study
Irene Ghobrial, MD, discusses the importance of the data made available through the Multiple Myeloma Research Foundation’s CureCloud research study.
A Novel Anti-CXCR4 Antibody for Relapsed/Refractory Multiple Myeloma
Irene Ghobrial, MD, director, Michele & Stephen Kirsch Laboratory, senior physician, Dana-Farber Cancer Center Institute, discusses the novel anti-CXCR4 ulocuplumab for the treatment of multiple myeloma.